Monthly shot study tests better dosing for opioid addiction
NCT ID NCT04995029
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 30 times
Summary
This study tested two different doses (100 mg vs 300 mg) of a monthly buprenorphine shot in 785 adults with moderate to severe opioid use disorder. The goal was to see which dose helped people stay in treatment and reduce opioid use. Results showed how well each dose worked for maintaining abstinence over several months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE OPIOID-USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Accel Research Sites- Lakeland Clinical Research Unit
Lakeland, Florida, 33803, United States
-
Alpine Research Organization
Clinton, Utah, 84015, United States
-
Artemis Institute for Clinical Research
San Diego, California, 92103, United States
-
Asclepes Research Centers
Panorama City, California, 91402, United States
-
Bay Pines VA Healthcare System
Bay Pines, Florida, 33744, United States
-
Behavioral Clinical Research, Inc
Miami Lakes, Florida, 33016, United States
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Carolina Medical Research, LLC
Clinton, South Carolina, 29325, United States
-
Carolina Medical Research, LLC
Greenville, South Carolina, 29607, United States
-
Center For Emotional Fitness
Cherry Hill, New Jersey, 08002, United States
-
Centre for Addiction and Mental Health
Toronto, Ontario, M6J 1H4, Canada
-
Clinical Neuroscience Solutions, Inc
Orlando, Florida, 32801, United States
-
Clinical Research Associates of Central PA
Altoona, Pennsylvania, 16602, United States
-
Collaborative Neuroscience Network, LLC
Garden Grove, California, 92845, United States
-
David Weitzman
Myrtle Beach, South Carolina, 29577, United States
-
Duke Hospital
Durham, North Carolina, 27705, United States
-
Hassman Research Institute
Berlin, New Jersey, 08009, United States
-
ICAHN School of Medicine at Mount Sinai
New York, New York, 10029, United States
-
Innovative Clinical Research Inc.
North Miami, Florida, 33161, United States
-
Insite Clinical Research
DeSoto, Texas, 75115, United States
-
Midwest Clinical Research
Dayton, Ohio, 45417, United States
-
Monroe Biomedical Research
Monroe, North Carolina, 28112, United States
-
Pahl Pharmaceutical Professionals LLC
Oklahoma City, Oklahoma, 73112, United States
-
Prisma Health ITOR Research Pharmacy
Greenville, South Carolina, 29605, United States
-
Progressive Clinical Research
Bountiful, Utah, 84010, United States
-
SP Research, PLLC
Oklahoma City, Oklahoma, 73112, United States
-
Sarkis Clinical Trials
Gainesville, Florida, 32607, United States
-
Today Clinical Research
Oklahoma City, Oklahoma, 73120, United States
-
Unity Clinical Research
Oklahoma City, Oklahoma, 73118, United States
Conditions
Explore the condition pages connected to this study.